Minicircle DNA is superior to plasmid DNA in eliciting antigen-specific CD8 + T-cell responses

Molecular Therapy

Volumn 21, Issue 8, 2013, Pages 1526-1535

  Dietz, Wynette M ^a   Skinner, Nicole E B ^a   Hamilton, Sara E ^a   Jund, Michelle D ^a   Heitfeld, Suzanne M ^a   Litterman, Adam J ^a   Hwu, Patrick ^b   Chen, Zhi Ying ^c   Salazar, Andres M ^d   Ohlfest, John R ^a   Blazar, Bruce R ^a   Pennell, Christopher A ^a   Osborn, Mark J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Shenzhen University Town   (China)

^d Oncovir   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYMETHYLCELLULOSE POLYCYTIDYLIC POLYINOSINIC ACID POLYLYSINE; DNA VACCINE; LUCIFERASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MINICIRCLE DNA; OVALBUMIN; PLASMID DNA; POLYINOSINIC POLYCYTIDYLIC ACID; SIINFEKL PEPTIDE; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; BACTERIAL LOAD; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DNA IMMUNIZATION; FEMALE; GENE EXPRESSION; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; LISTERIA MONOCYTOGENES; LISTERIOSIS; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; SPLEEN CELL;

BACTERIA (MICROORGANISMS); LISTERIA MONOCYTOGENES; MUS;

ADOPTIVE TRANSFER; ANIMALS; ANTIGEN PRESENTATION; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; DNA, CIRCULAR; EPITOPES, T-LYMPHOCYTE; FEMALE; GENE EXPRESSION; GENE ORDER; GENES, REPORTER; GENETIC VECTORS; HUMANS; LISTERIOSIS; MICE; PLASMIDS; SKIN; TRANSGENES; VACCINES, DNA;

EID: 84881317423     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2013.85     Document Type: Article

References (48)

1. Faurez, F, Dory, D, Le Moigne, V, Gravier, R and Jestin, A (2010). Biosafety of DNA vaccines: New generation of DNA vectors and current knowledge on the fate of plasmids after injection. Vaccine 28: 3888-3895.
2. Abdulhaqq, SA and Weiner, DB (2008). DNA vaccines: developing new strategies to enhance immune responses. Immunol Res 42: 219-232.
3. Ferraro, B, Morrow, MP, Hutnick, NA, Shin, TH, Lucke, CE and Weiner, DB (2011). Clinical applications of DNA vaccines: current progress. Clin Infect Dis 53: 296-302.
4. Chen, ZY, He, CY, Ehrhardt, A and Kay, MA (2003). Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Mol Ther 8: 495-500.
5. Chen, ZY, He, CY, Meuse, L and Kay, MA (2004). Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo. Gene Ther 11: 856-864.
6. Gracey Maniar, LE, Maniar, JM, Chen, ZY, Lu, J, Fire, AZ and Kay, MA (2013). Minicircle DNA vectors achieve sustained expression reflected by active chromatin and transcriptional level. Mol Ther 21: 131-138.
7. Chen, ZY, Riu, E, He, CY, Xu, H and Kay, MA (2008). Silencing of episomal transgene expression in liver by plasmid bacterial backbone DNA is independent of CpG methylation. Mol Ther 16: 548-556.
8. Riu, E, Chen, ZY, Xu, H, He, CY and Kay, MA (2007). Histone modifications are associated with the persistence or silencing of vector-mediated transgene expression in vivo. Mol Ther 15: 1348-1355.
9. Riu, E, Grimm, D, Huang, Z and Kay, MA (2005). Increased maintenance and persistence of transgenes by excision of expression cassettes from plasmid sequences in vivo. Hum Gene Ther 16: 558-570.
10. Lu, J, Zhang, F, Xu, S, Fire, AZ and Kay, MA (2012). The extragenic spacer length between the 5' and 3' ends of the transgene expression cassette affects transgene silencing from plasmid-based vectors. Mol Ther 20: 2111-2119.
11. Darquet, AM, Cameron, B, Wils, P, Scherman, D and Crouzet, J (1997). A new DNA vehicle for nonviral gene delivery: supercoiled minicircle. Gene Ther 4: 1341-1349.
12. Chen, ZY, He, CY and Kay, MA (2005). Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo. Hum Gene Ther 16: 126-131.
13. Kay, MA, He, CY and Chen, ZY (2010). A robust system for production of minicircle DNA vectors. Nat Biotechnol 28: 1287-1289.
14. Molnar, MJ, Gilbert, R, Lu, Y, Liu, AB, Guo, A, Larochelle, N et al. (2004). Factors influencing the efficacy, longevity, and safety of electroporation-assisted plasmidbased gene transfer into mouse muscles. Mol Ther 10: 447-455.
15. Nestle, FO, Di Meglio, P, Qin, JZ and Nickoloff, BJ (2009). Skin immune sentinels in health and disease. Nat Rev Immunol 9: 679-691.
16. Romani, N, Clausen, BE and Stoitzner, P (2010). Langerhans cells and more: langerinexpressing dendritic cell subsets in the skin. Immunol Rev 234: 120-141.
17. de Koning, HD, Rodijk-Olthuis, D, van Vlijmen-Willems, IM, Joosten, LA, Netea, MG, Schalkwijk, J et al. (2010). A comprehensive analysis of pattern recognition receptors in normal and inflamed human epidermis: upregulation of dectin-1 in psoriasis. J Invest Dermatol 130: 2611-2620.
18. Barry, MA and Johnston, SA (1997). Biological features of genetic immunization. Vaccine 15: 788-791.
19. Kang, MJ, Kim, CK, Kim, MY, Hwang, TS, Kang, SY, Kim, WK et al. (2004). Skin permeation, biodistribution, and expression of topically applied plasmid DNA. J Gene Med 6: 1238-1246.
20. Meykadeh, N, Mirmohammadsadegh, A, Wang, Z, Basner-Tschakarjan, E and Hengge, UR (2005). Topical application of plasmid DNA to mouse and human skin. J Mol Med 83: 897-903.
21. Gothelf, A, Eriksen, J, Hojman, P and Gehl, J (2010). Duration and level of transgene expression after gene electrotransfer to skin in mice. Gene Ther 17: 839-845.
22. van den Berg, JH, Nujien, B, Beijnen, JH, Vincent, A, van Tinteren, H, Kluge, J et al. (2009). Optimization of intradermal vaccination by DNA tattooing in human skin. Hum Gene Ther 20: 181-189.
23. Bins, AD, Jorritsma, A, Wolkers, MC, Hung, CF, Wu, TC, Schumacher, TN et al. (2005). A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression. Nat Med 11: 899-904.
24. Rabinovich, BA, Ye, Y, Etto, T, Chen, JQ, Levitsky, HI, Overwijk, WW et al. (2008). Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer. Proc Natl Acad Sci USA 105: 14342-
25. Hogquist, KA, Jameson, SC, Heath, WR, Howard, JL, Bevan, MJ and Carbone, FR (1994). T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
26. Kearney, ER, Pape, KA, Loh, DY and Jenkins, MK (1994). Visualization of peptidespecific T cell immunity and peripheral tolerance induction in vivo. Immunity 1: 327-339.
27. Altman, JD, Moss, PA, Goulder, PJ, Barouch, DH, McHeyzer-Williams, MG, Bell, JI et al. (1996). Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94-96.
28. Schorpp, M, Jäger, R, Schellander, K, Schenkel, J, Wagner, EF, Weiher, H et al. (1996). The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice. Nucleic Acids Res 24: 1787-1788.
29. Bellaiche, Y, Mogila, V and Perrimon, N (1999). I-SceI endonuclease, a new tool for studying DNA double-strand break repair mechanisms in Drosophila. Genetics 152: 1037-1044.
30. Porgador, A, Yewdell, JW, Deng, Y, Bennink, JR and Germain, RN (1997). Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6: 715-726.
31. Ingulli, E (2007). Tracing tolerance and immunity in vivo by CFSE-labeling of administered cells. Methods Mol Biol 380: 365-376.
32. Caskey, M, Lefebvre, F, Filali-Mouhim, A, Cameron, MJ, Goulet, JP, Haddad, EK et al. (2011). Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans. J Exp Med 208: 2357-2366.
33. Dudani, R, Chapdelaine, Y, Faassen Hv, Hv, Smith, DK, Shen, H, Krishnan, L et al. (2002). Multiple mechanisms compensate to enhance tumor-protective CD8(+) T cell response in the long-term despite poor CD8(+) T cell priming initially: comparison between an acute versus a chronic intracellular bacterium expressing a model antigen. J Immunol 168: 5737-5745.
34. Paul, ML, Dwyer, DE, Chow, C, Robson, J, Chambers, I, Eagles, G et al. (1994). Listeriosis-a review of eighty-four cases. Med J Aust 160: 489-493.
35. Kägi, D, Ledermann, B, Bürki, K, Hengartner, H and Zinkernagel, RM (1994). CD8+ T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. Eur J Immunol 24: 3068-3072.
36. Chirigos, MA, Schlick, E, Ruffmann, R, Budzynski, W, Sinibaldi, P and Gruys, E (1985). Pharmacokinetic and therapeutic activity of polyinosinic-polycytidylic acid stabilized with poly-L-lysine in carboxymethylcellulose [poly(I,C)-LC]. J Biol Response Mod 4: 621-627.
37. Stenler, S, Andersson, A, Simonson, OE, Lundin, KE, Chen, ZY, Kay, MA et al. (2009). Gene transfer to mouse heart and skeletal muscles using a minicircle expressing human vascular endothelial growth factor. J Cardiovasc Pharmacol 53: 18-23.
38. Zhang, X, Epperly, MW, Kay, MA, Chen, ZY, Dixon, T, Franicola, D et al. (2008). Radioprotection in vitro and in vivo by minicircle plasmid carrying the human manganese superoxide dismutase transgene. Hum Gene Ther 19: 820-826.
39. Darquet, AM, Rangara, R, Kreiss, P, Schwartz, B, Naimi, S, Delaère, P et al. (1999). Minicircle: an improved DNA molecule for in vitro and in vivo gene transfer. Gene Ther 6: 209-218.
40. Obar, JJ, Khanna, KM and Lefrançois, L (2008). Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection. Immunity 28: 859-869.
41. Bedoui, S, Davey, GM, Lew, AM and Heath, WR (2009). Equivalent stimulation of naive and memory CD8 T cells by DNA vaccination: a dendritic cell-dependent process. Immunol Cell Biol 87: 255-259.
42. Elnekave, M, Furmanov, K, Nudel, I, Arizon, M, Clausen, BE and Hovav, AH (2010). Directly transfected langerin+ dermal dendritic cells potentiate CD8+ T cell responses following intradermal plasmid DNA immunization. J Immunol 185: 3463-3471.
43. Osborn, MJ, McElmurry, RT, Lees, CJ, DeFeo, AP, Chen, ZY, Kay, MA et al. (2011). Minicircle DNA-based gene therapy coupled with immune modulation permits long-term expression of a-L-iduronidase in mice with mucopolysaccharidosis type I. Mol Ther 19: 450-460.
44. Hsieh, EA, Chai, CM, de Lumen, BO, Neese, RA and Hellerstein, MK (2004). Dynamics of keratinocytes in vivo using HO labeling: a sensitive marker of epidermal proliferation state. J Invest Dermatol 123: 530-536.
45. Biernaskie, J, Paris, M, Morozova, O, Fagan, BM, Marra, M, Pevny, L et al. (2009). SKPs derive from hair follicle precursors and exhibit properties of adult dermal stem cells. Cell Stem Cell 5: 610-623.
46. Bins, AD, Wolkers, MC, van den Boom, MD, Haanen, JB and Schumacher, TN (2007). In vivo antigen stability affects DNA vaccine immunogenicity. J Immunol 179: 2126-2133.
47. Hovav, AH, Panas, MW, Rahman, S, Sircar, P, Gillard, G, Cayabyab, MJ et al. (2007). Duration of antigen expression in vivo following DNA immunization modifies the magnitude, contraction, and secondary responses of CD8+ T lymphocytes. J Immunol 179: 6725-6733.
48. Gibson, DG, Young, L, Chuang, RY, Venter, JC, Hutchison, CA 3rd and Smith, HO (2009). Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods 6: 343-345.